Antiretroviral Herbal Remedy

Professor Duo Gao, a leading authority on Chinese Herbal Medicine, developed a formula composed of a number of natural herbs with significant antiretroviral properties. It was first tried in 2001, it resulted in the successful elimination of viral count and restoration in immunity level.

During the subsequent years, this treatment was provided to patients in the UK through various retail herbal clinics across the country. A large number of patients from South Africa also received this treatment from Professor Gao’s free treatment project between 2005 – 2006.

This formula has consistently lowered viral load and enhanced immunity counts for patients with varying profiles while producing absolutely no side effects even at higher doses.

This significant safety characteristic has been confirmed by an animal toxicity study carried out by reputable Chinese laboratory as well as the large number of patients who received this treatment.

In-vitro studies on the individual ingredients of this formula have shown that they are able to suppress the activities of different viral enzymes: Reverse Transcriptase, Integrase and Protease (See table below). By suppressing the viral activitities, the virus will not be able to reproduce itself. This will lead to the gradual decline in viral load. The suppresion of viral activities should also protect uninfected CD4 cells from further attacks so we can expect this treatment to also result in the stabilisation of immune counts followed by gradual recovery. This medicine is not intended to directly increase the CD4. It is primarily designed to suppress and eliminate the viral population. Consequently, the body's natural regeneration of the immune system will lead to the recovery of CD4 count when there are less viral activities attacking the uninfected CD4 cells.

This formula targets all 3 viral enzymes by combining different antiretroviral ingredients together. This means that when this formula is taken at sufficiently high dosages, it could produce results at least equivalent to that of combining all 3 classes of antiretroviral drugs (Reverse Transcriptase Inhibitor + Protease Inhibitor + Integrase Inhibitor) together but without the severe side effects such combination therapy could produce. Therefore it is superior to any individual conventional antiretroviral drugs, which are designed to target only one of the three viral enzymes.

In many cases, due to the severe side effects from conventional antiretroviral drugs many patients are unable to tolerate cocktail therapies, where a combination of different classes (Reverse Transcriptase Inhibitor i.e. Epivir, Integrase Inhibitor i.e. Raltegravir and Protease Inhibitor i.e. Lexiva) of antiretroviral drugs are prescribed in order to achieve better results. This medicine is an effective alternative if not a superior solution.

The results from our in-vitro studies (see table below) form the basis for the development of a new formula, which will be ready for trial at the end of 2008. It will consist of only the most potent ingredients thus should allow patients to achieve the same results while taking a significantly smaller dosage or significantly better results at the same dosage. We expect the new formula to have the same safety profile as what we have seen from the current formula.